Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 nCoV-19 in UK Healthy Adults
NCT04324606Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Apr 2020
- Primary completion
- Feb 2025
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by University of Oxford. Started Apr 2020; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04324606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04324606.